Global Influenza A Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Influenza A Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Influenza A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Influenza A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Influenza A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Influenza A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Influenza A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza A Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza A Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, GSK, Medimmune and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Influenza A Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Influenza A Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza A Vaccine, with price, sales, revenue and global market share of Influenza A Vaccine from 2018 to 2023.
Chapter 3, the Influenza A Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Influenza A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza A Vaccine.
Chapter 14 and 15, to describe Influenza A Vaccine sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global Influenza A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Influenza A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Influenza A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Influenza A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Influenza A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Influenza A Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Influenza A Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Sanofi, GSK, Medimmune and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Influenza A Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Intramuscular Vaccine
- Nasal Spray Vaccine
- 3-18 Years Old
- Above 18 Years Old
- Novartis
- Sanofi
- GSK
- Medimmune
- Abbott
- Mitsubishi Tanabe Pharma
- Merck
- Sinovac Biotech
- Hualan Biological Engineering
- Changsheng Bio-Technology
- Beijing Tiantan Bio-Products
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Influenza A Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Influenza A Vaccine, with price, sales, revenue and global market share of Influenza A Vaccine from 2018 to 2023.
Chapter 3, the Influenza A Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Influenza A Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Influenza A Vaccine.
Chapter 14 and 15, to describe Influenza A Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Influenza A Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza A Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Intramuscular Vaccine
1.3.3 Nasal Spray Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza A Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 3-18 Years Old
1.4.3 Above 18 Years Old
1.5 Global Influenza A Vaccine Market Size & Forecast
1.5.1 Global Influenza A Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Influenza A Vaccine Sales Quantity (2018-2029)
1.5.3 Global Influenza A Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Influenza A Vaccine Product and Services
2.1.4 Novartis Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Influenza A Vaccine Product and Services
2.2.4 Sanofi Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Influenza A Vaccine Product and Services
2.3.4 GSK Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Medimmune
2.4.1 Medimmune Details
2.4.2 Medimmune Major Business
2.4.3 Medimmune Influenza A Vaccine Product and Services
2.4.4 Medimmune Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Medimmune Recent Developments/Updates
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Influenza A Vaccine Product and Services
2.5.4 Abbott Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Recent Developments/Updates
2.6 Mitsubishi Tanabe Pharma
2.6.1 Mitsubishi Tanabe Pharma Details
2.6.2 Mitsubishi Tanabe Pharma Major Business
2.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
2.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Influenza A Vaccine Product and Services
2.7.4 Merck Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
2.8 Sinovac Biotech
2.8.1 Sinovac Biotech Details
2.8.2 Sinovac Biotech Major Business
2.8.3 Sinovac Biotech Influenza A Vaccine Product and Services
2.8.4 Sinovac Biotech Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Biotech Recent Developments/Updates
2.9 Hualan Biological Engineering
2.9.1 Hualan Biological Engineering Details
2.9.2 Hualan Biological Engineering Major Business
2.9.3 Hualan Biological Engineering Influenza A Vaccine Product and Services
2.9.4 Hualan Biological Engineering Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hualan Biological Engineering Recent Developments/Updates
2.10 Changsheng Bio-Technology
2.10.1 Changsheng Bio-Technology Details
2.10.2 Changsheng Bio-Technology Major Business
2.10.3 Changsheng Bio-Technology Influenza A Vaccine Product and Services
2.10.4 Changsheng Bio-Technology Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Changsheng Bio-Technology Recent Developments/Updates
2.11 Beijing Tiantan Bio-Products
2.11.1 Beijing Tiantan Bio-Products Details
2.11.2 Beijing Tiantan Bio-Products Major Business
2.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
2.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Tiantan Bio-Products Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLUENZA A VACCINE BY MANUFACTURER
3.1 Global Influenza A Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Influenza A Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Influenza A Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Influenza A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Influenza A Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Influenza A Vaccine Manufacturer Market Share in 2022
3.5 Influenza A Vaccine Market: Overall Company Footprint Analysis
3.5.1 Influenza A Vaccine Market: Region Footprint
3.5.2 Influenza A Vaccine Market: Company Product Type Footprint
3.5.3 Influenza A Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Influenza A Vaccine Market Size by Region
4.1.1 Global Influenza A Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Influenza A Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Influenza A Vaccine Average Price by Region (2018-2029)
4.2 North America Influenza A Vaccine Consumption Value (2018-2029)
4.3 Europe Influenza A Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Influenza A Vaccine Consumption Value (2018-2029)
4.5 South America Influenza A Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Influenza A Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Influenza A Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Influenza A Vaccine Consumption Value by Type (2018-2029)
5.3 Global Influenza A Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Influenza A Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Influenza A Vaccine Consumption Value by Application (2018-2029)
6.3 Global Influenza A Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Influenza A Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Influenza A Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Influenza A Vaccine Market Size by Country
7.3.1 North America Influenza A Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Influenza A Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Influenza A Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Influenza A Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Influenza A Vaccine Market Size by Country
8.3.1 Europe Influenza A Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Influenza A Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Influenza A Vaccine Market Size by Region
9.3.1 Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Influenza A Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Influenza A Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Influenza A Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Influenza A Vaccine Market Size by Country
10.3.1 South America Influenza A Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Influenza A Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Influenza A Vaccine Market Size by Country
11.3.1 Middle East & Africa Influenza A Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Influenza A Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Influenza A Vaccine Market Drivers
12.2 Influenza A Vaccine Market Restraints
12.3 Influenza A Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Influenza A Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza A Vaccine
13.3 Influenza A Vaccine Production Process
13.4 Influenza A Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza A Vaccine Typical Distributors
14.3 Influenza A Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Influenza A Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Influenza A Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Intramuscular Vaccine
1.3.3 Nasal Spray Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Influenza A Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 3-18 Years Old
1.4.3 Above 18 Years Old
1.5 Global Influenza A Vaccine Market Size & Forecast
1.5.1 Global Influenza A Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Influenza A Vaccine Sales Quantity (2018-2029)
1.5.3 Global Influenza A Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Influenza A Vaccine Product and Services
2.1.4 Novartis Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Influenza A Vaccine Product and Services
2.2.4 Sanofi Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 GSK
2.3.1 GSK Details
2.3.2 GSK Major Business
2.3.3 GSK Influenza A Vaccine Product and Services
2.3.4 GSK Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GSK Recent Developments/Updates
2.4 Medimmune
2.4.1 Medimmune Details
2.4.2 Medimmune Major Business
2.4.3 Medimmune Influenza A Vaccine Product and Services
2.4.4 Medimmune Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Medimmune Recent Developments/Updates
2.5 Abbott
2.5.1 Abbott Details
2.5.2 Abbott Major Business
2.5.3 Abbott Influenza A Vaccine Product and Services
2.5.4 Abbott Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Abbott Recent Developments/Updates
2.6 Mitsubishi Tanabe Pharma
2.6.1 Mitsubishi Tanabe Pharma Details
2.6.2 Mitsubishi Tanabe Pharma Major Business
2.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
2.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Influenza A Vaccine Product and Services
2.7.4 Merck Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Merck Recent Developments/Updates
2.8 Sinovac Biotech
2.8.1 Sinovac Biotech Details
2.8.2 Sinovac Biotech Major Business
2.8.3 Sinovac Biotech Influenza A Vaccine Product and Services
2.8.4 Sinovac Biotech Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sinovac Biotech Recent Developments/Updates
2.9 Hualan Biological Engineering
2.9.1 Hualan Biological Engineering Details
2.9.2 Hualan Biological Engineering Major Business
2.9.3 Hualan Biological Engineering Influenza A Vaccine Product and Services
2.9.4 Hualan Biological Engineering Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hualan Biological Engineering Recent Developments/Updates
2.10 Changsheng Bio-Technology
2.10.1 Changsheng Bio-Technology Details
2.10.2 Changsheng Bio-Technology Major Business
2.10.3 Changsheng Bio-Technology Influenza A Vaccine Product and Services
2.10.4 Changsheng Bio-Technology Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Changsheng Bio-Technology Recent Developments/Updates
2.11 Beijing Tiantan Bio-Products
2.11.1 Beijing Tiantan Bio-Products Details
2.11.2 Beijing Tiantan Bio-Products Major Business
2.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
2.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Beijing Tiantan Bio-Products Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: INFLUENZA A VACCINE BY MANUFACTURER
3.1 Global Influenza A Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Influenza A Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Influenza A Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Influenza A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Influenza A Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Influenza A Vaccine Manufacturer Market Share in 2022
3.5 Influenza A Vaccine Market: Overall Company Footprint Analysis
3.5.1 Influenza A Vaccine Market: Region Footprint
3.5.2 Influenza A Vaccine Market: Company Product Type Footprint
3.5.3 Influenza A Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Influenza A Vaccine Market Size by Region
4.1.1 Global Influenza A Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Influenza A Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Influenza A Vaccine Average Price by Region (2018-2029)
4.2 North America Influenza A Vaccine Consumption Value (2018-2029)
4.3 Europe Influenza A Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Influenza A Vaccine Consumption Value (2018-2029)
4.5 South America Influenza A Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Influenza A Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Influenza A Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Influenza A Vaccine Consumption Value by Type (2018-2029)
5.3 Global Influenza A Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Influenza A Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Influenza A Vaccine Consumption Value by Application (2018-2029)
6.3 Global Influenza A Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Influenza A Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Influenza A Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Influenza A Vaccine Market Size by Country
7.3.1 North America Influenza A Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Influenza A Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Influenza A Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Influenza A Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Influenza A Vaccine Market Size by Country
8.3.1 Europe Influenza A Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Influenza A Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Influenza A Vaccine Market Size by Region
9.3.1 Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Influenza A Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Influenza A Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Influenza A Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Influenza A Vaccine Market Size by Country
10.3.1 South America Influenza A Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Influenza A Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Influenza A Vaccine Market Size by Country
11.3.1 Middle East & Africa Influenza A Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Influenza A Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Influenza A Vaccine Market Drivers
12.2 Influenza A Vaccine Market Restraints
12.3 Influenza A Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Influenza A Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Influenza A Vaccine
13.3 Influenza A Vaccine Production Process
13.4 Influenza A Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Influenza A Vaccine Typical Distributors
14.3 Influenza A Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Influenza A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Influenza A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Influenza A Vaccine Product and Services
Table 6. Novartis Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Influenza A Vaccine Product and Services
Table 11. Sanofi Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Influenza A Vaccine Product and Services
Table 16. GSK Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Medimmune Basic Information, Manufacturing Base and Competitors
Table 19. Medimmune Major Business
Table 20. Medimmune Influenza A Vaccine Product and Services
Table 21. Medimmune Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Medimmune Recent Developments/Updates
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Influenza A Vaccine Product and Services
Table 26. Abbott Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abbott Recent Developments/Updates
Table 28. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Mitsubishi Tanabe Pharma Major Business
Table 30. Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
Table 31. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 33. Merck Basic Information, Manufacturing Base and Competitors
Table 34. Merck Major Business
Table 35. Merck Influenza A Vaccine Product and Services
Table 36. Merck Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Recent Developments/Updates
Table 38. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Biotech Major Business
Table 40. Sinovac Biotech Influenza A Vaccine Product and Services
Table 41. Sinovac Biotech Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Biotech Recent Developments/Updates
Table 43. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Biological Engineering Major Business
Table 45. Hualan Biological Engineering Influenza A Vaccine Product and Services
Table 46. Hualan Biological Engineering Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hualan Biological Engineering Recent Developments/Updates
Table 48. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 49. Changsheng Bio-Technology Major Business
Table 50. Changsheng Bio-Technology Influenza A Vaccine Product and Services
Table 51. Changsheng Bio-Technology Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Changsheng Bio-Technology Recent Developments/Updates
Table 53. Beijing Tiantan Bio-Products Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Tiantan Bio-Products Major Business
Table 55. Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
Table 56. Beijing Tiantan Bio-Products Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Tiantan Bio-Products Recent Developments/Updates
Table 58. Global Influenza A Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Influenza A Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Influenza A Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Influenza A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Influenza A Vaccine Production Site of Key Manufacturer
Table 63. Influenza A Vaccine Market: Company Product Type Footprint
Table 64. Influenza A Vaccine Market: Company Product Application Footprint
Table 65. Influenza A Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Influenza A Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Influenza A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Influenza A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Influenza A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Influenza A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Influenza A Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Influenza A Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Influenza A Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Influenza A Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Influenza A Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Influenza A Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Influenza A Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Influenza A Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Influenza A Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Influenza A Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Influenza A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Influenza A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Influenza A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Influenza A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Influenza A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Influenza A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Influenza A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Influenza A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Influenza A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Influenza A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Influenza A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Influenza A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Influenza A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Influenza A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Influenza A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Influenza A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Influenza A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Influenza A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Influenza A Vaccine Raw Material
Table 126. Key Manufacturers of Influenza A Vaccine Raw Materials
Table 127. Influenza A Vaccine Typical Distributors
Table 128. Influenza A Vaccine Typical Customers
Table 1. Global Influenza A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Influenza A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Influenza A Vaccine Product and Services
Table 6. Novartis Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Influenza A Vaccine Product and Services
Table 11. Sanofi Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. GSK Basic Information, Manufacturing Base and Competitors
Table 14. GSK Major Business
Table 15. GSK Influenza A Vaccine Product and Services
Table 16. GSK Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GSK Recent Developments/Updates
Table 18. Medimmune Basic Information, Manufacturing Base and Competitors
Table 19. Medimmune Major Business
Table 20. Medimmune Influenza A Vaccine Product and Services
Table 21. Medimmune Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Medimmune Recent Developments/Updates
Table 23. Abbott Basic Information, Manufacturing Base and Competitors
Table 24. Abbott Major Business
Table 25. Abbott Influenza A Vaccine Product and Services
Table 26. Abbott Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Abbott Recent Developments/Updates
Table 28. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Mitsubishi Tanabe Pharma Major Business
Table 30. Mitsubishi Tanabe Pharma Influenza A Vaccine Product and Services
Table 31. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 33. Merck Basic Information, Manufacturing Base and Competitors
Table 34. Merck Major Business
Table 35. Merck Influenza A Vaccine Product and Services
Table 36. Merck Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Merck Recent Developments/Updates
Table 38. Sinovac Biotech Basic Information, Manufacturing Base and Competitors
Table 39. Sinovac Biotech Major Business
Table 40. Sinovac Biotech Influenza A Vaccine Product and Services
Table 41. Sinovac Biotech Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sinovac Biotech Recent Developments/Updates
Table 43. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 44. Hualan Biological Engineering Major Business
Table 45. Hualan Biological Engineering Influenza A Vaccine Product and Services
Table 46. Hualan Biological Engineering Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Hualan Biological Engineering Recent Developments/Updates
Table 48. Changsheng Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 49. Changsheng Bio-Technology Major Business
Table 50. Changsheng Bio-Technology Influenza A Vaccine Product and Services
Table 51. Changsheng Bio-Technology Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Changsheng Bio-Technology Recent Developments/Updates
Table 53. Beijing Tiantan Bio-Products Basic Information, Manufacturing Base and Competitors
Table 54. Beijing Tiantan Bio-Products Major Business
Table 55. Beijing Tiantan Bio-Products Influenza A Vaccine Product and Services
Table 56. Beijing Tiantan Bio-Products Influenza A Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Beijing Tiantan Bio-Products Recent Developments/Updates
Table 58. Global Influenza A Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global Influenza A Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global Influenza A Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in Influenza A Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and Influenza A Vaccine Production Site of Key Manufacturer
Table 63. Influenza A Vaccine Market: Company Product Type Footprint
Table 64. Influenza A Vaccine Market: Company Product Application Footprint
Table 65. Influenza A Vaccine New Market Entrants and Barriers to Market Entry
Table 66. Influenza A Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Influenza A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global Influenza A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global Influenza A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global Influenza A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global Influenza A Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global Influenza A Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global Influenza A Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global Influenza A Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global Influenza A Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global Influenza A Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global Influenza A Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global Influenza A Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global Influenza A Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global Influenza A Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America Influenza A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America Influenza A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America Influenza A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America Influenza A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe Influenza A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe Influenza A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe Influenza A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Influenza A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific Influenza A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific Influenza A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific Influenza A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America Influenza A Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America Influenza A Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America Influenza A Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America Influenza A Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa Influenza A Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa Influenza A Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa Influenza A Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa Influenza A Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa Influenza A Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa Influenza A Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 125. Influenza A Vaccine Raw Material
Table 126. Key Manufacturers of Influenza A Vaccine Raw Materials
Table 127. Influenza A Vaccine Typical Distributors
Table 128. Influenza A Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Influenza A Vaccine Picture
Figure 2. Global Influenza A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Influenza A Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Intramuscular Vaccine Examples
Figure 5. Nasal Spray Vaccine Examples
Figure 6. Global Influenza A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Influenza A Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 3-18 Years Old Examples
Figure 9. Above 18 Years Old Examples
Figure 10. Global Influenza A Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Influenza A Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Influenza A Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Influenza A Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Influenza A Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Influenza A Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Influenza A Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Influenza A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Influenza A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Influenza A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Influenza A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Influenza A Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Influenza A Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Influenza A Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Influenza A Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Influenza A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Influenza A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Influenza A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Influenza A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Influenza A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Influenza A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Influenza A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Influenza A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Influenza A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Influenza A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Influenza A Vaccine Market Drivers
Figure 73. Influenza A Vaccine Market Restraints
Figure 74. Influenza A Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Influenza A Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Influenza A Vaccine
Figure 78. Influenza A Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Influenza A Vaccine Picture
Figure 2. Global Influenza A Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Influenza A Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Intramuscular Vaccine Examples
Figure 5. Nasal Spray Vaccine Examples
Figure 6. Global Influenza A Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Influenza A Vaccine Consumption Value Market Share by Application in 2022
Figure 8. 3-18 Years Old Examples
Figure 9. Above 18 Years Old Examples
Figure 10. Global Influenza A Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Influenza A Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Influenza A Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Influenza A Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Influenza A Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Influenza A Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Influenza A Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Influenza A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Influenza A Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Influenza A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Influenza A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Influenza A Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Influenza A Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Influenza A Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Influenza A Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Influenza A Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Influenza A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Influenza A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Influenza A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Influenza A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Influenza A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Influenza A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Influenza A Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Influenza A Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Influenza A Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Influenza A Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Influenza A Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Influenza A Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Influenza A Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Influenza A Vaccine Market Drivers
Figure 73. Influenza A Vaccine Market Restraints
Figure 74. Influenza A Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Influenza A Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Influenza A Vaccine
Figure 78. Influenza A Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
